The nine included PwCF for the functional assays were selected as presenting with severe CF based on their high sweat chloride levels (> 60 mmol/L), exocrine pancreas insufficiency and both CFTR variants belonging to mutation classes I or II. The gene discussed is CFTR; the disease is exocrine pancreatic insufficiency.